← Eichor
Study identifier: NCT06184464 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prostatic Size Reduction Following of Leuprorelin Acetate

Condition: Prostate Cancer Adenocarcinoma · Prostate Adenocarcinoma  ·  Sponsor: Consorci Sanitari de Terrassa

PhaseN/A
Planned participants40
Who can joinMale, 18 Years to 95 Years
Healthy volunteersNo

About this study

To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

nicolas feltes  ·  619-819-9500  ·  nicofeltes_81@hotmail.com

nicolas feltes  ·  nicofeltes_81@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital de TerrassaTerrassa, Barcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06184464